Among all the genetic susceptible risk factors associated with IBD, the first identified was nucleotide-binding oligomerization domain 2 (NOD2), which has been characteristic of recognizing and responding to bacteria and inducing a program of antimicrobial and inflammatory gene expression. The gene discussed is NOD2; the disease is inflammatory bowel disease.